Cyclo Therapeutics Stock (NASDAQ:CYTH), Quotes and News Summary

Q: What sector and industry does Cyclo Therapeutics (CYTH) operate in?

Cyclo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Cyclo Therapeutics Stock (NASDAQ: CYTH) stock price, news, charts, stock research, profile.

Open	$1.180
Close	$1.200
Volume / Avg.	29.552K / 107.502K
Day Range	1.170 - 1.248
52 Wk Range	0.680 - 2.570
Market Cap	$31.874M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	27
Short Interest	0.18%
Days to Cover	1

Recent News

Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.

Avi Kapoor

Why Bridgeline Digital Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket

Shares of Bridgeline Digital, Inc. (NASDAQ: BLIN) fell sharply in pre-market following the release of fourth-quarter results. Bridgeline Digital posted a narrower-than-expected loss for its fourth quarter, while sales missed estimates.

Avi Kapoor

Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Cyclo Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company is engaged in developing ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cyclo Therapeutics (CYTH) stock?

You can purchase shares of Cyclo Therapeutics (NASDAQ: CYTH) through any online brokerage.

View our list of the best stock brokerages.

Who are Cyclo Therapeutics's (CYTH) competitors?

Other companies in Cyclo Therapeutics’s space includes: Serina Therapeutics (AMEX:SER), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).

What is the target price for Cyclo Therapeutics (CYTH) stock?

The latest price target for Cyclo Therapeutics (NASDAQ: CYTH) was reported by Maxim Group on Wednesday, September 27, 2023. The analyst firm set a price target for 4.00 expecting CYTH to rise to within 12 months (a possible 260.36% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Cyclo Therapeutics (CYTH)?

The stock price for Cyclo Therapeutics (NASDAQ: CYTH) is $1.11 last updated Today at April 18, 2024 at 4:16 PM EDT.

Does Cyclo Therapeutics (CYTH) pay a dividend?

There are no upcoming dividends for Cyclo Therapeutics.

When is Cyclo Therapeutics (NASDAQ:CYTH) reporting earnings?

Cyclo Therapeutics’s Q1 earnings are confirmed for Monday, May 13, 2024.

Is Cyclo Therapeutics (CYTH) going to split?

There is no upcoming split for Cyclo Therapeutics.

What sector and industry does Cyclo Therapeutics (CYTH) operate in?

Cyclo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-